Lauren Wood
Keine laufenden Positionen mehr
Vermögen: - $ am 31.03.2024
Profil
Lauren V.
Wood worked as the Clinical Director at the National Cancer Institute.
She then worked at the Center for Cancer Research as the Head of the Vaccine Branch Clinical Trials Team from 2005 to 2017.
Currently, she is the Chief Medical Officer at PDS Biotechnology Corp.
She completed her undergraduate degree at Oberlin College and her doctorate at Duke University School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
PDS BIOTECHNOLOGY CORP.
-.--% | 22.05.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Ehemalige bekannte Positionen von Lauren Wood
| Unternehmen | Position | Ende |
|---|---|---|
| PDS BIOTECHNOLOGY CORPORATION | Chief Tech/Sci/R&D Officer | 22.01.2024 |
| Center for Cancer Research | Corporate Officer/Principal | 01.01.2017 |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - |
Ausbildung von Lauren Wood
| Oberlin College | Undergraduate Degree |
| Duke University School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PDS BIOTECHNOLOGY CORPORATION | Health Technology |
| Private Unternehmen | 2 |
|---|---|
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
| Center for Cancer Research | Government |
